Peripheral Inflammation Is Associated With Greater Neuronal Injury and Lower Episodic Memory Among Late Middle-Aged
Mona-Lisa Malarte1, Konstantinos Chiotis1,2, Konstantinos Ioannou1
1Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Peripheral inflammation, not amyloid-beta or tau, is linked to early memory issues in preclinical Alzheimer's disease (AD). This highlights the importance of inflammation and neurodegeneration markers for early AD detection and prevention strategies.
Area of Science:
- Neuroscience
- Immunology
- Gerontology
Background:
- Alzheimer's disease (AD) early detection relies on understanding preclinical mechanisms.
- Amyloid-beta (Aβ) and tau pathologies are key, but peripheral factors are underexplored.
- Investigating peripheral inflammation's role in early AD pathogenesis is crucial.
Purpose of the Study:
- To examine tau positron emission tomography (PET) and peripheral inflammation in relation to Aβ burden and neurodegeneration.
- To assess the association of these markers with cognitive function and comorbidities in cognitively unimpaired adults.
- To explore the interplay between central and peripheral mechanisms in early AD.
Main Methods:
- Utilized 18F-MK6240 tau PET imaging in 132 cognitively unimpaired Hispanic adults.
- Measured plasma neurofilament light (NfL) for neuronal injury and peripheral inflammatory markers.
- Analyzed associations between Aβ, tau, inflammation, NfL, cognitive performance, and comorbidities (BMI, DM).
Main Results:
- Early tau deposition was observed even without significant NfL elevation.
- Peripheral inflammation correlated with NfL but not directly with Aβ or tau.
- Episodic memory impairment was linked to inflammation and NfL, not Aβ or tau.
- Aβ and tau were influenced by genetics and sex; inflammation by NfL, BMI, and DM.
Conclusions:
- Peripheral inflammation and neurodegeneration markers are associated with early cognitive changes in preclinical AD.
- Findings suggest integrating peripheral markers into AD progression models for better risk stratification.
- Targeting inflammation and vascular health may offer novel strategies for AD prevention.
More Related Videos
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
09:55Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses
Published on: February 3, 2022
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Neural Regulation
Inflammation
Role of Cerebellum and Prefrontal Cortex in Memory
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
